Trial Profile
A Program to Evaluate Riastap and FIBTEM for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Postpartum haemorrhage
- Focus Pharmacodynamics
- Acronyms PERFECT PPH
- 10 Mar 2021 Status changed from suspended to withdrawn prior to enrolment as study never began.
- 10 Mar 2021 Planned initiation date changed from 1 Sep 2016 to 1 Jan 2021.
- 28 Oct 2020 Planned primary completion date changed from 1 Jan 2020 to 1 Dec 2021.